Teicoplanin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Teicoplanin and local guidelines before prescribing.
Mechanism
Glycopeptide inhibiting cell-wall synthesis.
Uses
MRSA and resistant Gram-positive infection, endocarditis, bone and joint infection.
Dosing
- Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Rash, fever, thrombocytopenia, injection-site reactions; less nephrotoxic than vancomycin.
Interactions
Aminoglycosides increase nephrotoxicity and ototoxicity.
Contraindications and cautions
Glycopeptide allergy
Monitoring
Levels, renal function
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Loading doses needed; trough level monitoring in serious infection.
More from the textbook: uses, cautions and other points
- MRSA suspected: Add vancomycin or teicoplanin.
Respiratory: Emergencies - Add vancomycin or teicoplanin for suspected line infection, MRSA or skin infection; antifungals for persistent fever (after 4–7 days).
Oncology: Emergencies - Severe or systemically unwell - IV flucloxacillin (or co-amoxiclav, cefuroxime, ceftriaxone, clindamycin per local policy); MRSA - vancomycin, teicoplanin or linezolid.
Dermatology: Skin infections and infestations - Cell wall | Beta-lactams (penicillins, cephalosporins, carbapenems, aztreonam) - bind penicillin-binding proteins; glycopeptides (vancomycin, teicoplanin)
ID: How Infection Happens - MRSA (meticillin-resistant S. aureus) - resistant to flucloxacillin and most beta-lactams; treat with vancomycin, teicoplanin, linezolid, daptomycin, or doxycycline or co-trimoxazole for milder infections (depending on sensitivities); decolonise (nasal mupirocin and chlorhexidine body wash) before some surgery.
ID: How Infection Happens - Line infection | Staphylococci (including CoNS, MRSA), Gram-negatives, Candida | Vancomycin or teicoplanin ± Gram-negative cover; remove the line in many cases
ID: Sepsis, fever and serious bacterial infections
Where it is discussed in the book
- Respiratory: Emergencies (1 mention)
- Oncology: Emergencies (1 mention)
- Dermatology: Skin infections and infestations (1 mention)
- ID: How Infection Happens (5 mentions)
- ID: Sepsis, fever and serious bacterial infections (2 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (4 mentions)
- Anaesthesia: Airway management and anaesthetic drugs (2 mentions)
- Integrated respiratory chapter (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)